Home › Endocrine Diseases › NCT03050762
Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
RecruitingObservational study
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: 1. All patients that are being seen at MD Anderson with diagnosed or suspected endocrine disease. Patients will be selected from patients undergoing evaluation and/or treatment in the Endocrine Center, either by selection from a participating Endocrine physician or by screening from study personnel for patients scheduled to be seen in the Endocrine Clinic. 2. In addition, we intend to contact family members of patients who are enrolled on the study, and found to be deceased at follow-up, to request permission to obtain cause of death, to determine whether cause of death may be related to endocrine disease. Exclusion Criteria: N/A
About the study
The goal of this data review study is to collect data to learn more about thyroid, parathyroid, and adrenal disease.
What is being tested
- Data Collection (other)
- Follow Up (behavioral)
Sponsor: M.D. Anderson Cancer Center · Participants: 15,000 · Started: Oct 5, 2011
Contact the study team
- Nancy D. Perrier, MD · Phone: 713-792-6940
Official record on ClinicalTrials.gov — NCT03050762
Locations in the U.S.
| Texas | University of Texas MD Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.